Clinical Trials Directory

Trials / Completed

CompletedNCT01476930

Cupping and Serkangabin Versus Conventional Migraine Treatment

Cupping Therapy and SERKANGABIN Versus Conventional Treatment of Migraine Headache: a Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
391 (actual)
Sponsor
Birjand University of Medical Sciences · Academic / Other
Sex
All
Age
15 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Migraine is the most common recurrent headache. Current therapy of migraine headache consists of multiple drug groups for control of attack and prophylaxis against recurrent attacks. Emerging alternative medicine worldwide led investigators to evaluate the efficacy of cupping therapy plus SERKANGABIN syrup in treatment of migraine headache. Severity, duration and frequency of attacks of migraine headache evaluated in two groups during six months from presentation.

Detailed description

In a randomized controlled trial investigators randomly assigned 76 patients with migraine to cupping therapy plus SERKANGABIN or to receive conventional medical treatment. The use of CAM in migraine is a growing phenomenon. Migraine patients seek and explore both conventional and CAM approaches. Wet cupping is an ancient medical technique still used in several contemporary societies. It is being used in management of hypertension, diabetes mellitus, and headaches, renal and biliary stones and for maintaining health. Little experimental study has been devoted to test its efficacy to treat migraine headache. Investigators planned this study for evaluation of therapeutic efficacy of wet cupping and an Iranian traditional medicine preparation, SERKANGABIN in treatment of migraine headache compared with current medicine protocols. SERKANGABIN is a preparation of honey, vinegar and distilled mint water that in traditional Iranian medicine is believed to have therapeutic effects in many diseases (diabetes mellitus, hypertension, hyperlipidemia, osteoarthritis, chronic obstructive airway disease, interstitial lung disease, hepatitis, fatty liver, ischemic heart disease, migraine, cerebrovascular diseases)

Conditions

Interventions

TypeNameDescription
PROCEDUREcupping and serkangabin syrupwet cupping serkangabin syrup
DRUGconventional migraine drug treatmentnortriptyline ,propranolol ,ergotamine , sumatriptan tablets

Timeline

Start date
2008-06-01
Primary completion
2009-09-01
Completion
2011-10-01
First posted
2011-11-22
Last updated
2014-11-24

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01476930. Inclusion in this directory is not an endorsement.